Oruka Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oruka Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2023.
  • Oruka Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $112K, a 40.1% decline year-over-year.
  • Oruka Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $521K, a 14.3% decline year-over-year.
  • Oruka Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $686K, a 23.4% increase from 2022.
  • Oruka Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $556K, a 11.9% increase from 2021.
  • Oruka Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $497K, a 1056% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $686K +$130K +23.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-01
2022 $556K +$59K +11.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-01
2021 $497K +$454K +1056% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 $43K -$108K -71.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $151K -$122K -44.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 $273K -$185K -40.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-18
2017 $458K -$118K -20.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-27
2016 $576K -$23K -3.84% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-22
2015 $599K -$48K -7.42% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-21
2014 $647K +$364K +129% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-17
2013 $283K -$23K -7.52% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-19
2012 $306K -$2K -0.65% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-20
2011 $308K Jan 1, 2011 Dec 31, 2011 10-K 2013-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.